Bibliographic Details
| Title: |
The effect of genetic polymorphisms in UGT2B15 on the pharmacokinetic profile of sipoglitazar, a novel anti-diabetic agent. |
| Authors: |
Stringer F; Takeda Pharmaceutical Company, 1-1, Doshomachi 4-Chome, Chuo-Ku, Osaka 540-8645, Japan. fran.stringer@takeda.com, Scott G, Valbuena M, Kinley J, Nishihara M, Urquhart R |
| Source: |
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2013 Mar; Vol. 69 (3), pp. 423-30. Date of Electronic Publication: 2012 Sep 09. |
| Publication Type: |
Clinical Trial, Phase I; Journal Article |
| Journal Info: |
Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1041 (Electronic) Linking ISSN: 00316970 NLM ISO Abbreviation: Eur J Clin Pharmacol Subsets: MEDLINE |
| Database: |
MEDLINE Ultimate |
